Data Bridge Market Research analyses that the rare hemophilia factors market which was USD 78.83 billion in 2021, would rocket up to USD 126.59 billion by 2029, and is expected to undergo a CAGR of 6.10% during the forecast period 2022 to 2029.
menu
- home Home
- newspaper News
- feed Guest Post
- attach_money Price
- contact_support Contact
- monetization_on Donate/Support
-
English- English (en)
- Arabic (ar)
- Chinese Simplified (zh_CN)
- French (fr)
- German (de)
- Hindi (hi)
- Irish (ga)
- Italian (it)
- Japanese (ja)
- Korean (ko)
- Russian (ru)
- Spanish (es)
- Turkish (tr)
- Urdu (ur)
- Bengali (bn)
- Afrikaans (af)
- Greek (el)
- Indonesian (id)
- Georgian (ka)
- Dutch (nl)
- Portuguese (Brazil) (pt_BR)
- Vietnamese (vi)
- Ukrainian (uk)
- Filipino (tl)
Copyright © 2025 Times Square Reporter. All rights reserved.
Comments
0 comment